BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 30558569)

  • 1. Improving women's knowledge about prenatal screening in the era of non-invasive prenatal testing for Down syndrome - development and acceptability of a low literacy decision aid.
    Smith SK; Cai A; Wong M; Sousa MS; Peate M; Welsh A; Meiser B; Kaur R; Halliday J; Lewis S; Trevena L; Yanes T; Barlow-Stewart K; Barclay M
    BMC Pregnancy Childbirth; 2018 Dec; 18(1):499. PubMed ID: 30558569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Psychosocial Factors and Health Literacy in Pregnant Women's Intention to Use a Decision Aid for Down Syndrome Screening: A Theory-Based Web Survey.
    Delanoë A; Lépine J; Turcotte S; Leiva Portocarrero ME; Robitaille H; Giguère AM; Wilson BJ; Witteman HO; Lévesque I; Guillaumie L; Légaré F
    J Med Internet Res; 2016 Oct; 18(10):e283. PubMed ID: 27793792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pregnant women's views on how to promote the use of a decision aid for Down syndrome prenatal screening: a theory-informed qualitative study.
    Agbadjé TT; Menear M; Dugas M; Gagnon MP; Rahimi SA; Robitaille H; Giguère AMC; Rousseau F; Wilson BJ; Légaré F
    BMC Health Serv Res; 2018 Jun; 18(1):434. PubMed ID: 29884169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Talking Points: Women's Information Needs for Informed Decision-Making About Noninvasive Prenatal Testing for Down Syndrome.
    Dane AC; Peterson M; Miller YD
    J Genet Couns; 2018 Sep; 27(5):1258-1264. PubMed ID: 29550971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of a decision aid for prenatal testing of fetal abnormalities to improve women's informed decision making: a cluster randomised controlled trial [ISRCTN22532458].
    Nagle C; Gunn J; Bell R; Lewis S; Meiser B; Metcalfe S; Ukoumunne OC; Halliday J
    BJOG; 2008 Feb; 115(3):339-47. PubMed ID: 18190370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Women's Experience with Non-Invasive Prenatal Testing and Emotional Well-being and Satisfaction after Test-Results.
    van Schendel RV; Page-Christiaens GCML; Beulen L; Bilardo CM; de Boer MA; Coumans ABC; Faas BHW; van Langen IM; Lichtenbelt KD; van Maarle MC; Macville MVE; Oepkes D; Pajkrt E; Henneman L;
    J Genet Couns; 2017 Dec; 26(6):1348-1356. PubMed ID: 28667567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health literacy in pregnant women facing prenatal screening may explain their intention to use a patient decision aid: a short report.
    Delanoë A; Lépine J; Leiva Portocarrero ME; Robitaille H; Turcotte S; Lévesque I; Wilson BJ; Giguère AM; Légaré F
    BMC Res Notes; 2016 Jul; 9():339. PubMed ID: 27401163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Facilitating informed choice about non-invasive prenatal testing (NIPT): a systematic review and qualitative meta-synthesis of women's experiences.
    Cernat A; De Freitas C; Majid U; Trivedi F; Higgins C; Vanstone M
    BMC Pregnancy Childbirth; 2019 Jan; 19(1):27. PubMed ID: 30642270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trial by Dutch laboratories for evaluation of non-invasive prenatal testing. Part II-women's perspectives.
    van Schendel RV; Page-Christiaens GC; Beulen L; Bilardo CM; de Boer MA; Coumans AB; Faas BH; van Langen IM; Lichtenbelt KD; van Maarle MC; Macville MV; Oepkes D; Pajkrt E; Henneman L;
    Prenat Diagn; 2016 Dec; 36(12):1091-1098. PubMed ID: 27739584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-invasive prenatal screening for trisomy 21: what women want and are willing to pay.
    Verweij EJ; Oepkes D; de Vries M; van den Akker ME; van den Akker ES; de Boer MA
    Patient Educ Couns; 2013 Dec; 93(3):641-5. PubMed ID: 24011429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-invasive prenatal testing (NIPT) and pregnant women's views on good motherhood: a qualitative study.
    Garcia E; Henneman L; Gitsels-van der Wal JT; Martin L; Koopmanschap I; Bekker MN; Timmermans DRM
    Eur J Hum Genet; 2022 Jun; 30(6):669-675. PubMed ID: 34400811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reasons for accepting or declining Down syndrome screening in Dutch prospective mothers within the context of national policy and healthcare system characteristics: a qualitative study.
    Crombag NM; Boeije H; Iedema-Kuiper R; Schielen PC; Visser GH; Bensing JM
    BMC Pregnancy Childbirth; 2016 May; 16(1):121. PubMed ID: 27229318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 'Small cost to pay for peace of mind': Women's experiences with non-invasive prenatal testing.
    Bowman-Smart H; Savulescu J; Mand C; Gyngell C; Pertile MD; Lewis S; Delatycki MB
    Aust N Z J Obstet Gynaecol; 2019 Oct; 59(5):649-655. PubMed ID: 30724335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of a patient decision aid for prenatal screening for Down syndrome: what do pregnant women say?
    Portocarrero ME; Giguère AM; Lépine J; Garvelink MM; Robitaille H; Delanoë A; Lévesque I; Wilson BJ; Rousseau F; Légaré F
    BMC Pregnancy Childbirth; 2017 Mar; 17(1):90. PubMed ID: 28320334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Women's preference for non-invasive prenatal DNA testing versus chromosomal microarray after screening for Down syndrome: a prospective study.
    Cheng Y; Leung WC; Leung TY; Choy KW; Chiu R; Lo TK; Kwok KY; Sahota DS
    BJOG; 2018 Mar; 125(4):451-459. PubMed ID: 29125674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenatal screening for Down syndrome in Australia: costs and benefits of current and novel screening strategies.
    O'Leary P; Maxwell S; Murch A; Hendrie D
    Aust N Z J Obstet Gynaecol; 2013 Oct; 53(5):425-33. PubMed ID: 24090461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 'It made you think twice' - an interview study of women's perception of a web-based decision aid concerning screening and diagnostic testing for fetal anomalies.
    Åhman A; Sarkadi A; Lindgren P; Rubertsson C
    BMC Pregnancy Childbirth; 2016 Sep; 16(1):267. PubMed ID: 27619366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canadian Pregnant Women's Preferences Regarding NIPT for Down Syndrome: The Information They Want, How They Want to Get It, and With Whom They Want to Discuss It.
    Laberge AM; Birko S; Lemoine MÈ; Le Clerc-Blain J; Haidar H; Affdal AO; Dupras C; Ravitsky V
    J Obstet Gynaecol Can; 2019 Jun; 41(6):782-791. PubMed ID: 30738740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A meta-synthesis of pregnant women's decision-making processes with regard to antenatal screening for Down syndrome.
    Reid B; Sinclair M; Barr O; Dobbs F; Crealey G
    Soc Sci Med; 2009 Dec; 69(11):1561-73. PubMed ID: 19783085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.